Should antioxidant status be considered in interventional trials with antioxidants?

被引:32
作者
Violi, F [1 ]
Loffredo, L [1 ]
Musella, L [1 ]
Marcoccia, A [1 ]
机构
[1] Univ Roma La Sapienza, Div Clin Med 4, I-00161 Rome, Italy
关键词
D O I
10.1136/hrt.2003.026930
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The last decade has seen many trials with antioxidants in patients with cardiovascular disease, with equivocal results. One possible explanation for the disappointing findings is the lack of identification criteria of patients who are potential candidates for antioxidant treatment. Several studies have been carried out in patients at risk of cardiovascular disease, indicating that enhanced oxidative stress is associated with the presence of diabetes, hypercholesterolaemia, hypertension, and smoking. This review analyses the data reported so far to determine whether they clearly support the premise that patients at risk of cardiovascular events may be candidates for antioxidant treatment.
引用
收藏
页码:598 / 602
页数:5
相关论文
共 48 条
[1]   Investigation into the sources of superoxide in human blood vessels - Angiotensin II increases superoxide production in human internal mammary arteries [J].
Berry, C ;
Hamilton, CA ;
Brosnan, J ;
Magill, FG ;
Berg, GA ;
McMurray, JJV ;
Dominiczak, AF .
CIRCULATION, 2000, 101 (18) :2206-2212
[2]   NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat [J].
Beswick, RA ;
Dorrance, AM ;
Leite, R ;
Webb, RC .
HYPERTENSION, 2001, 38 (05) :1107-1111
[3]   Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers [J].
Carroll, MF ;
Schade, DS .
CIRCULATION, 2003, 108 (01) :24-31
[4]  
Cosentino F, 1997, CIRCULATION, V96, P25
[5]   Platelet activation in obese women -: Role of inflammation and oxidant stress [J].
Davì, G ;
Guagnano, MT ;
Ciabattoni, G ;
Basili, S ;
Falco, A ;
Marinopiccoli, M ;
Nutini, M ;
Sensi, S ;
Patrono, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2008-2014
[6]   In vivo formation of 8-epi-prostaglandin F-2 alpha is increased in hypercholesterolemia [J].
Davi, G ;
Alessandrini, P ;
Mezzetti, A ;
Minotti, G ;
Bucciarelli, T ;
Costantini, F ;
Cipollone, F ;
Bon, GB ;
Ciabattoni, G ;
Patrono, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :3230-3235
[7]   Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension [J].
Duffy, SJ ;
Gokce, N ;
Holbrook, M ;
Hunter, LM ;
Biegelsen, ES ;
Huang, AO ;
Keaney, JF ;
Vita, JA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (02) :H528-H534
[8]   Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia [J].
Ferro, D ;
Parrotto, S ;
Basili, S ;
Alessandri, C ;
Violi, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) :427-+
[9]  
GGEY KF, 1993, VITAMIN E HLTH DIS, P589
[10]  
GODE P, 2001, DIABETIC MED, V18, P756